These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16321540)

  • 1. ORL1 and opioid receptor preferences of nociceptin and dynorphin A analogues with Dmp substituted for N-terminal aromatic residues.
    Sasaki Y; Kawano S; Kohara H; Watanabe H; Ambo A
    Bioorg Med Chem; 2006 Apr; 14(7):2433-7. PubMed ID: 16321540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the substitution of Phe4 in the opioid peptide [D-Ala8]dynorphin A-(1-11)NH2.
    Vig BS; Zheng MQ; Murray TF; Aldrich JV
    J Med Chem; 2003 Sep; 46(19):4002-8. PubMed ID: 12954053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the structure-activity relationships of nociceptin and dynorphin A using chimeric peptides.
    Lapalu S; Moisand C; Mazarguil H; Cambois G; Mollereau C; Meunier JC
    FEBS Lett; 1997 Nov; 417(3):333-6. PubMed ID: 9409745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynorphin A analogs containing a conformationally constrained phenylalanine derivative in position 4: reversal of preferred stereochemistry for opioid receptor affinity and discrimination of kappa vs. delta receptors.
    Aldrich JV; Zheng QI; Murray TF
    Chirality; 2001; 13(3):125-9. PubMed ID: 11270320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion of delta-, kappa- and mu-receptor selective opioid peptide agonists into delta-, kappa- and mu-selective antagonists.
    Schiller PW; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Lu Y
    Life Sci; 2003 Jun; 73(6):691-8. PubMed ID: 12801590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [2',6'-Dimethyltyrosine]dynorphin A(1-11)-NH2 analogues lacking an N-terminal amino group: potent and selective kappa opioid antagonists.
    Lu Y; Nguyen TM; Weltrowska G; Berezowska I; Lemieux C; Chung NN; Schiller PW
    J Med Chem; 2001 Sep; 44(19):3048-53. PubMed ID: 11543672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3.
    Vig BS; Murray TF; Aldrich JV
    J Med Chem; 2004 Jan; 47(2):446-55. PubMed ID: 14711314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of modifications of residues in position 3 of dynorphin A(1-11)-NH2 on kappa receptor selectivity and potency.
    Lung FD; Meyer JP; Lou BS; Xiang L; Li G; Davis P; DeLeon IA; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 1996 Jun; 39(13):2456-60. PubMed ID: 8691442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies.
    Varani K; Rizzi A; Calo G; Bigoni R; Toth G; Guerrini R; Gessi S; Salvadori S; Borea PA; Regoli D
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):270-7. PubMed ID: 10543428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A structure-activity study of nociceptin-(1-13)-peptide amide. Synthesis of analogues substituted in positions 0, 1, 3, 4 and 10.
    Bobrova I; Vlaskovska M; Kasakov L; Surovoy A; Egorova N; Johansson L; Karsnas P; Terenius L
    Eur J Med Chem; 2003; 38(7-8):687-94. PubMed ID: 12932899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and opioid activity of [D-Pro10]dynorphin A-(1-11) analogues with N-terminal alkyl substitution.
    Choi H; Murray TF; DeLander GE; Schmidt WK; Aldrich JV
    J Med Chem; 1997 Aug; 40(17):2733-9. PubMed ID: 9276018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermorphin tetrapeptide analogues with 2',6'-dimethylphenylalanine (Dmp) substituted for aromatic amino acids have high mu opioid receptor binding and biological activities.
    Ambo A; Niizuma H; Sasaki A; Kohara H; Sasaki Y
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1269-72. PubMed ID: 12657261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different domains of the ORL1 and kappa-opioid receptors are involved in recognition of nociceptin and dynorphin A.
    Lapalu S; Moisand C; Butour JL; Mollereau C; Meunier JC
    FEBS Lett; 1998 May; 427(2):296-300. PubMed ID: 9607332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of highly potent and selective dynorphin A analogues as new medicines.
    Lung FD; Chen CH; Liu JH
    J Pept Res; 2005 Nov; 66(5):263-76. PubMed ID: 16218994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 2. Conformational constraint in the "address" sequence.
    Arttamangkul S; Ishmael JE; Murray TF; Grandy DK; DeLander GE; Kieffer BL; Aldrich JV
    J Med Chem; 1997 Apr; 40(8):1211-8. PubMed ID: 9111295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design of dynorphin A analogues with delta-receptor selectivity and antagonism for delta- and kappa-receptors.
    Guerrini R; Capasso A; Marastoni M; Bryant SD; Cooper PS; Lazarus LH; Temussi PA; Salvadori S
    Bioorg Med Chem; 1998 Jan; 6(1):57-62. PubMed ID: 9502105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct mechanisms for activation of the opioid receptor-like 1 and kappa-opioid receptors by nociceptin and dynorphin A.
    Mollereau C; Mouledous L; Lapalu S; Cambois G; Moisand C; Butour JL; Meunier JC
    Mol Pharmacol; 1999 Feb; 55(2):324-31. PubMed ID: 9927625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 1. Conformational constraint in the "message" sequence.
    Arttamangkul S; Murray TF; DeLander GE; Aldrich JV
    J Med Chem; 1995 Jun; 38(13):2410-7. PubMed ID: 7608905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of opioid receptor-like receptor ORL1 for chemical modification on nociceptin, a naturally occurring nociceptive peptide.
    Shimohigashi Y; Hatano R; Fujita T; Nakashima R; Nose T; Sujaku T; Saigo A; Shinjo K; Nagahisa A
    J Biol Chem; 1996 Sep; 271(39):23642-5. PubMed ID: 8798582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2',6'-dimethylphenylalanine (Dmp) can mimic the N-terminal Tyr in opioid peptides.
    Sasaki Y; Sasaki A; Ariizumi T; Igari Y; Sato K; Kohara H; Niizuma H; Ambo A
    Biol Pharm Bull; 2004 Feb; 27(2):244-7. PubMed ID: 14758045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.